Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has provided an announcement.
Jubilant Pharmova Limited has announced a final dividend of Rs. 5 per equity share for the fiscal year ending March 31, 2025, pending shareholder approval at the upcoming Annual General Meeting. The company has also communicated the tax implications of this dividend, highlighting that taxes will be withheld at varying rates based on shareholder status and provided documentation, with no tax for resident individuals receiving dividends under INR 10,000.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its contributions to healthcare through its innovative solutions and has a significant presence in the market.
Average Trading Volume: 17,379
Technical Sentiment Signal: Strong Buy
Current Market Cap: 184.9B INR
Learn more about JUBLPHARMA stock on TipRanks’ Stock Analysis page.